Download PDF
Minim Invasive Neurosurg 2006; 49(3): 135-142
DOI: 10.1055/s-2006-932216
Original Article
© Georg Thieme Verlag Stuttgart · New York

Minimally Invasive Photodynamic Therapy (PDT) for Ablation of Experimental Rat Glioma

H.  Hirschberg1, 2, 3 , S.  Spetalen4 , S.  Carper5, 6 , P.  Hole7 , T.  Tillung7 , S.  Madsen3, 5
  • 1Department of Neurosurgery, Rikshospitalet, Oslo, Norway
  • 2Beckman Laser Institute, University of California, Irvine, Irvine, CA, USA
  • 3Department of Health Physics, University of Nevada, Las Vegas, NV, USA
  • 4Department of Pathology, Ullevaal University Hospital, Oslo, Norway
  • 5UNLV Cancer Research Center, University of Nevada, Las Vegas, NV, USA
  • 6Department of Chemistry, University of Nevada, Las Vegas, NV, USA
  • 7Interventional Center, Rikshospitalet, Oslo, Norway
Further Information

Publication History

Publication Date:
18 July 2006 (online)

    Permissions and Reprints

Abstract

Objective: The feasibility of using ALA-mediated photodynamic therapy (PDT) tumor ablation as a minimally invasive treatment alternative for malignant brain tumors was evaluated in a rodent model. Treatment efficacy and side effects were evaluated with MRI, histopathology and survival rates. Methods: BT4C orthotopic brain tumors were induced in BD-IX rats. At various time intervals following tumor induction the animals were given 5-aminolevulinic acid (ALA) and 4 hours later optical fibers were inserted directly into the tumor without mechanical debulking or cranial decompression. A 3-day course of steroid treatment was initiated immediately prior to PDT. Results: All untreated animals inevitably died within one month after tumor implantation (28.5 ± 2.5 days). Complete tumor eradication was achieved in only 1/17 rats, but a significant increase in survival was obtained in the group of animals receiving 125 mg/kg ALA and 26 Joules of light fluence. Histopathology revealed large areas of central tumor necrosis, although clusters of viable tumor cells were often found at the tumor periphery. Pronounced edema in the necrotic tumor center as well as in the surrounding brain, and along white matter tracts was evident in all the brains studied from PDT-treated animal. Conclusion: This study suggests that ALA-mediated PDT may become a promising alternative therapy for the minimally invasive treatment of brain tumors. A judicious choice of PDT regimens that minimizes inflammatory responses through the use multiple fractionated long-term treatment protocols would likely be required.

Key words

Glioma - tumor ablation - photodynamic therapy - rodent model

References

  • 1 Dougherty T J, Gomer C J, Henderson B W, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Review: Photodynamic therapy.  J Nat Can Inst. 1998;  90 889-905
    CrossrefPubMedGoogle Scholar
  • 2 Peng Q, Berg K, Moan J, Kongshaug M, Nesland J M. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research.  Photochem Photobiol. 1997;  65 235-251
    CrossrefPubMedGoogle Scholar
  • 3 Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky K-E, Nesland J M. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges.  Cancer. 1997;  79 2282-2308
    CrossrefPubMedGoogle Scholar
  • 4 Tsai J-C, Hsiao Y Y, Teng L-J, Chen C-T, Kao M-C. Comparative study on the ALA photodynamic effects of human glioma and meningioma cells.  Lasers Surg Med. 1999;  24 296-305
    CrossrefPubMedGoogle Scholar
  • 5 Hebeda K M, Saarnak A E, Olivo M. 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain.  Acta Neurochirurgica. 1998;  140 503-513
    CrossrefPubMedGoogle Scholar
  • 6 Olzowy B, Hundt C S, Stocker S, Bise K, Reulen H J, Stummer W. Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid.  J Neurosurg. 2002;  97 970-976
    PubMedGoogle Scholar
  • 7 Lilge L, Wilson B C. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.  J Clin Laser Med Surg. 1998;  16 81-82
    PubMedGoogle Scholar
  • 8 Hirschberg H, Angell-Petersen E, Peng Q, Madsen S J, Sioud M, Sørensen D. Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma.  Proc SPIE. 2004;  5312 405-414
    PubMedGoogle Scholar
  • 9 Angell-Petersen E, Spetalen S, Madsen S J, Sun C-H, Peng Q, Carper S W, Sioud M, Hirschberg H. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model.  J Neurosurg. 2006;  104 109-117
    PubMedGoogle Scholar
  • 10 Marcus F. The use of radiofrequency energy for intracranial ablation: historical perspectives and results of experiments in animals. In: Breithardt G, Borggrefe M, Zipes D (eds). Non-Pharmacological Therapy of Tachyarrhythmias. Mount Kisco, NY 213-219
    Google Scholar
  • 11 Anzai Y, Lufkin R, DeSalles A, Hamilton D R, Farahani K, Black K L. Preliminary experience with MR-guided thermal ablation of brain tumors.  AJNR Am J Neuroradiol. 1995;  16 39-48
    PubMedGoogle Scholar
  • 12 Kahn T, Harth T, Bettag M, Schwabe B, Ulrich F, Schwarzmaier H J, Modder U. Preliminary experience with the application of gadolinium-DTPA before MR imaging-guided laser-induced interstitial thermotherapy of brain tumors.  J Magn Reson Imaging. 1997;  7 226-229
    PubMedGoogle Scholar
  • 13 Yi M, Ni Y, Yu J, Zhang H, Marchal G. Evaluation of radiofrequency ablation as an alternative for the treatment of brain tumor in rabbits.  J Neurooncol. 2002;  56 119-126
    CrossrefPubMedGoogle Scholar
  • 14 Leonardi M A, Lumenta C B, Gumprecht H K, Einsiedel G H von, Wilhelm T. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR-unit.  Minim Invas Neurosurg. 2001;  44 37-42
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Leonardi M A, Lumenta C B. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical experience.  Minim Invas Neurosurg. 2002;  45 201-207
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Laerum O D, Rajewsky M F, Schachner M, Stavrou D, Haglid K G, Haugen A. Phenotypic properties of neoplastic cell lines developed from fetal rat brain cells in culture after exposure to ethylnitrosourea in vivo.  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977;  89 273-295
    PubMedGoogle Scholar
  • 17 Mella O, Bjerkvig R, Schem B C, Dahl O, Laerum O D. A cerebral glioma model for experimental therapy and in vivo invasion studies in syngeneic BD-IX rats.  J Neurooncol. 1990;  9 93-104
    CrossrefPubMedGoogle Scholar
  • 18 Angell-Petersen E, Sørensen D R, Madsen S J, Hirschberg H. Interstitial light application for repetitive photodynamic therapy in a rat brain tumor model. Proceeding SPIE, Vol. 5312 2004: 415-423
    Google Scholar
  • 19 Chen Q, Chopp M, Madigan L, Dereski M O, Hetzel F W. Damage threshold of normal rat brain in photodynamic therapy.  Photochem Photobiol. 1996;  64 163-167
    PubMedGoogle Scholar
  • 20 Dereski M O, Chopp M, Chen Q, Hetzel F W. Normal brain tissue response to photodynamic therapy: histology, vascular permeability and specific gravity.  Photochem Photobiol. 1989;  50 653-657
    PubMedGoogle Scholar
  • 21 Ji Y, Powers S K, Brown T J, Walsted D, Maliner L. Toxicity of photodynamic therapy with Photofrin in the normal rat brain.  Lasers Surg Med. 1994;  14 219-228
    PubMedGoogle Scholar
  • 22 Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz A E, Kiefmann R, Reulen H J. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.  Neurosurgery. 1998;  42 518-525
    CrossrefPubMedGoogle Scholar
  • 23 Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen H J. Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins. A prospective study in 52 consecutive patients.  J Neurosurg. 2000;  93 1003-1013
    CrossrefPubMedGoogle Scholar
  • 24 Hirschberg H, Angell-Petersen E, Peng Q, Sorensen D R, Sun C H, Carper S W, Madsen S J. ALA mediated Photodynamic Therapy of experimental malignant glioma in the BD-IX rat model.  Proceeding SPIE  Vol. 6, no.1 2005;  513-521
    PubMedGoogle Scholar
  • 25 Lilge L, Portnoy M, Wilson B C. PDT-induced apoptosis in brain tissue in vivo: Apoptosis following PDT in normal and VX2 tumor-bearing rabbit brain. Proceedings SPIE Vol. 3592 1999: 28-36
    Google Scholar
  • 26 Hirschberg H, Sun C H, Tromberg B J, Madsen S J. Enhanced effects of concurrent 5-aminolevulinic acid-mediated photodynamic therapy by hyperthermia on glioma spheroids.  J Neurooncol. 2004;  70 289-299
    CrossrefPubMedGoogle Scholar
  • 27 Obwegeser A, Jakober R, Kostron H. Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolevulinic acid in the C6 rat glioma model.  Br J Cancer. 1998;  78 733-788
    PubMedGoogle Scholar
  • 28 Ji Y, Walstad D L, Brown J T, Powers S K. Relation between porphyrin distribution and blood brain barrier changes in the rat glioma model.  Lasers Surg Med. 1992;  12 174-179
    PubMedGoogle Scholar
  • 29 Reulen H J, Graham R, Spatz M, Klatzo I. Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema.  J Neurosurg. 1977;  46 24-35
    PubMedGoogle Scholar
  • 30 Ji Y, Powers S K, Brown T J, Walsted D, Maliner L. Toxicity of photodynamic therapy with Photofrin in the normal rat brain.  Lasers Surg Med. 1994;  14 219-228
    PubMedGoogle Scholar
  • 31 Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neurosurgery: a review.  J Photochem Photobiol B. 1996;  36 157-168
    CrossrefPubMedGoogle Scholar
  • 32 Ito S, Rachinger W, Stepp H, Reulen H J, Stummer W. Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA.  Acta Neurochir (Wien). 2005;  147 57-65
    CrossrefPubMedGoogle Scholar
  • 33 Ji Y, Walstad D, Brown J T, Powers S K. Improved survival from intracavitary photodynamic therapy of rat glioma.  Photochem Photobiol. 1992;  56 385-390
    PubMedGoogle Scholar
  • 34 Muller P. PDT for primary brain tumors.  Photodynamic News. 1999;  2 2-5
    PubMedGoogle Scholar
  • 35 Lobel J, MacDonald I J, Ciesielski M J, Barone T, Potter W R, Pollina J. et al . 2-[1-Hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.  Lasers Surg Med. 2001;  29 397-405
    CrossrefPubMedGoogle Scholar
  • 36 Kowalczuk A, Macdonald R L, Amidei C. et al . Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.  Neurosurgery. 1997;  41 1028-1038
    PubMedGoogle Scholar
  • 37 Lacroix M, Abi-Said D, Fourney D R, Gokaslan Z L, Shi W, DeMonte F, Lang F F, McCutcheon I E, Hassenbusch S J, Holland E, Hess K, Michael C, Miller D, Sawaya R. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.  J Neurosurg. 2001;  95 190-198
    Google Scholar
  • 38 Woodward D E, Cook J, Tracqui P, Cruywagen G C, Murray J D, Alvord Jr E C. A mathematical model of glioma growth: the effect of extent of surgical resection.  Cell Prolif. 1996;  29 269-288
    PubMedGoogle Scholar
  • 39 Swanson K R, Bridge C, Murray J D, Alvord Jr E C. Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion.  J Neurol Sci. 2003;  216 1-10
    CrossrefPubMedGoogle Scholar
  • 40 Madsen S J, Sun C H, Tromberg B J, Hirschberg H. Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy.  Lasers Surg Med. 2001;  29 406-412
    CrossrefPubMedGoogle Scholar
  • 41 Bisland S K, Lilge L, Lin A, Rusnov R, Wilson B C. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors.  Photochem Photobiol. 2004;  80 22-30
    CrossrefPubMedGoogle Scholar

Henry Hirschberg, M. D., Ph. D. 

Department of Neurosurgery · Rikshospitalet

0027 Oslo

Norway ·

Phone: +47/230/74323

Email: hhirschb@uci.edu